De Rop, Florian V. http://orcid.org/0000-0001-5241-924X
Hulselmans, Gert
Flerin, Chris http://orcid.org/0000-0003-1883-871X
Soler-Vila, Paula
Rafels, Albert
Christiaens, Valerie
González-Blas, Carmen Bravo
Marchese, Domenica
Caratù, Ginevra http://orcid.org/0000-0003-1085-8062
Poovathingal, Suresh
Rozenblatt-Rosen, Orit http://orcid.org/0000-0001-6313-3570
Slyper, Michael
Luo, Wendy http://orcid.org/0000-0002-7041-823X
Muus, Christoph http://orcid.org/0000-0003-2779-0893
Duarte, Fabiana http://orcid.org/0000-0002-1261-4929
Shrestha, Rojesh
Bagdatli, S. Tansu
Corces, M. Ryan http://orcid.org/0000-0001-7465-7652
Mamanova, Lira
Knights, Andrew
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Mulqueen, Ryan http://orcid.org/0000-0002-3903-7594
Taherinasab, Akram
Maschmeyer, Patrick
Pezoldt, Jörn http://orcid.org/0000-0001-7143-5691
Lambert, Camille Lucie Germaine
Iglesias, Marta http://orcid.org/0000-0003-1757-7343
Najle, Sebastián R. http://orcid.org/0000-0002-0654-9147
Dossani, Zain Y. http://orcid.org/0000-0001-9264-6340
Martelotto, Luciano G.
Burkett, Zach http://orcid.org/0000-0002-5153-485X
Lebofsky, Ronald http://orcid.org/0000-0002-3728-6415
Martin-Subero, José Ignacio http://orcid.org/0000-0001-8809-5195
Pillai, Satish
Sebé-Pedrós, Arnau http://orcid.org/0000-0002-9896-9746
Deplancke, Bart http://orcid.org/0000-0001-9935-843X
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Ludwig, Leif S. http://orcid.org/0000-0002-2916-2164
Braun, Theodore P.
Adey, Andrew C. http://orcid.org/0000-0001-7648-8717
Greenleaf, William J. http://orcid.org/0000-0003-1409-3095
Buenrostro, Jason D. http://orcid.org/0000-0001-9958-3987
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Aerts, Stein http://orcid.org/0000-0002-8006-0315
Heyn, Holger http://orcid.org/0000-0002-3276-1889
Article History
Received: 18 January 2022
Accepted: 22 June 2023
First Online: 3 August 2023
Competing interests
: H.H. is a cofounder and equity holder of Omniscope, a Scientific Advisory Board member of MiRXES and a consultant to Moderna. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was a Scientific Advisory Board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. A.R. is an employee of Genentech and has equity in Roche. O.R.-R. is an employee of Genentech. A.R. and O.R.-R. are co-inventors on patent applications filed by the Broad Institute relating to single-cell genomics. In the past 3 years, S.A.T. has received remuneration for Scientific Advisory Board Membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a cofounder of and holds equity in Transition Bio. 10x Genomics has licensed intellectual property on which W.J.G. is listed as an inventor. W.J.G. holds options in 10x Genomics and is a consultant for Ultima Genomics, Guardant Health. W.J.G. is a scientific cofounder of Protillion Biosciences. J.D.B. holds patents related to ATAC-seq and SHARE-seq and is a Scientific Advisory Board member of Camp4 and seqWell. A.A. is an author on licensed patents that cover the nucleosome disruption and indexed tagmentation design. L.L. holds a patent for lineage tracing using mitochondrial genome mutations and single-cell genomics and is a consultant to Cartography Biosciences. B.D. is cofounder and shareholder of Alithea Genomics. The remaining authors declare no competing interests.